Concentra Group Holdings Parent, Inc.

Concentra Group Holdings Parent, Inc.

CONNYSE / NASDAQHealthcareMid cap

$41.84+$0.39 (+0.9%)

Last close · Data as of Nov 20, 2026

Market cap
$3.2B
P/E
19.2x
EV / EBITDA
12.7x
Revenue
$2.2B
Net margin
7.7%
ROCE
13.2%

+115.0% over the last year

Concentra Group Holdings Parent, Inc. price, 1Y

Daily closes.

Go deeper

Technical chart: candles, 28 indicators including moving averages, RSI and MACD, drawing tools and five colour themes

Open technical chart
Open technical chartCandles, 28 indicators, drawing tools

Performance

Price return, before dividends, to the 20 Nov 2026 close.

1M
+7.9%
3M
+20.2%
6M
+64.6%
1Y
+115.0%
5Y
Short history
  • A period is left blank when the price history is shorter than the period.

52-week range

Day change +$0.39 (+0.9%) from $41 to $42 · Last close Nov 20, 2026

Best weekday to invest, historically

The same weekly amount in CON, bought on each weekday since 2024.

News & filings

What Concentra Group Holdings Parent filed, who traded, and what's next

How to read this

"News & filings" lists what the company itself has put on record with regulators, who inside it traded, the news that names it, and the next date we know of. Filings and releases are first-hand; news is third-party and may be thin for smaller companies. A day of insider filings is one row. Nothing here is a recommendation.

AI Summary

US Stock

StrengthThe price is 39.4% above its 200-day average, and the 50-day average is above the 200-day.

Concerns

No concern stands out for this company on the data on file.

Prices to the 20 Nov 2026 close · Financial year: fiscal 2025

Rule-based from financial data. Not advice.

About the company

Concentra Group Holdings Parent, Inc. provides occupational health services in the United States. The company operates in three segments: Occupational Health centers, Onsite health clinics, and Other business.

Read moreShow less

Concentra Group Holdings Parent, Inc. provides occupational health services in the United States. The company operates in three segments: Occupational Health centers, Onsite health clinics, and Other business. It offers occupational health services, including workers compensation, employer, and consumer health services; and employer-sponsored primary care services at workplace, including mobile health and episodic specialty testing services. It also operates Concentra Telemed, a telemedicine platform for the treatment of work-related injuries and illnesses; Concentra Pharmacy for distributing repackaged medications; and Concentra Medical Compliance Administration, a third-party administrator that helps to manage abuse testing programs for employers with regulated or non-regulated workforces. In addition, the company provides injury care, primary care, urgent care, preventive care, clinical testing, physical examinations and evaluations, drug and alcohol screenings, clinical testing, vaccinations and other preventive care, and a range of consultative services designed to protect employees from workplace hazards. The company was founded in 1979 and is based in Addison, Texas.

Sector
Healthcare
Shares outstanding
128.0M

Valuation, profitability, growth and solvency at the latest close; hover a label for its meaning.

Valuation

Market cap
$3.2B
P/E
19.2x
P/B
8.1x
EV / EBITDA
12.7x
EV / Sales
2.4x
P/S
1.5x
52-week high
$43.56
52-week low
$19.28

Profitability

Operating margin
15.4%
Net margin
7.7%
EBITDA margin
18.9%
ROE
42.3%
ROCE
13.2%
ROA
5.8%
Asset turnover
0.76

Growth

Revenue
$2.2B
Revenue growth, 1Y
13.9%
Revenue CAGR, 3Y
7.9%
Net profit growth, 1Y
-0.1%
Free cash flow
$197.1M

Solvency

Current ratio
1.14
Debt / Equity
5.35
Debt / Assets
0.74
CFO / Net profit
1.68
Cash / Market cap
2.5%

Where the revenue went

Of every $100 of FY2025 revenue, $8 was left as net income.

Concentra Group Holdings Parent, Inc. income statement flow, FY2025
Concentra Group Holdings Parent, Inc. income statement flow, FY2025: flows
FromToAmount
RevenueCost of revenue$1.6B
RevenueGross profit$613.1M
Gross profitSelling, general and administrative$203.3M
Gross profitOther operating expenses$75.8M
Gross profitOperating income$334.0M
Operating incomePretax income$223.8M
Operating incomeInterest and other expense$110.2M
Pretax incomeTax and other$57.4M
Pretax incomeNet income$166.4M

Revenue and net profit

Revenue grew 13.9% in FY2025; net profit is the dashed line.

Concentra Group Holdings Parent, Inc. revenue and net profit by fiscal year
Concentra Group Holdings Parent, Inc. revenue and net profit by fiscal year
DateRevenueNet profit
FY2022$1.7B$166.7M
FY2023$1.8B$179.9M
FY2024$1.9B$166.5M
FY2025$2.2B$166.4M

Cash flows

FY2025: $279.4M from operations, $197.1M free after investment (dashed).

Concentra Group Holdings Parent, Inc. operating and free cash flow by fiscal year
Concentra Group Holdings Parent, Inc. operating and free cash flow by fiscal year
DateOperating cash flowFree cash flow
FY2022$274.3M$228.4M
FY2023$234.3M$165.0M
FY2024$274.7M$210.3M
FY2025$279.4M$197.1M

Growth

Latest fiscal year 2025: each figure with its change over the year before.

Revenue
$2.2B+13.9%1Y
EBITDA
$408.9M+11.0%1Y
Net profit
$166.4M-0.1%1Y
Cash from operations
$279.4M+1.7%1Y
Free cash flow
$197.1M-6.3%1Y
Revenue CAGR, 3Y
7.9%
Net profit CAGR, 3Y
-0.1%
YearRevenueEBITDANet profitFCFROERevenue growth 1YNet profit growth 1Y
FY2025$2.2B$408.9M$166.4M$197.1M42.3%+13.9%-0.1%

Monthly returns

Month-by-month returns of CON across the years, with the seasonal pattern.

Balance sheet

What the company owns and owes at the end of FY2025.

LineFY2025
Assets$2.9B
Liabilities$2.4B
Equity$420.4M
Paid-in capital$248.9M
Retained earnings$146.4M
Minority interest$27.1M

Market cap against peers

8 peers: same sector, nearest by size.

Peers map

Healthcare companies placed by value, growth and quality; CON highlighted.

P/E against peers

CON trades at 19.2x earnings against a peer median of 26.9x (a 29% discount).

Not shown (no positive earnings and no EV / Sales): Arcus Biosciences, Inc.

Peer comparison

Same-sector peers by market cap, with the median.

CompanyMarket capP/EP/BROEEV/EBITDA
Concentra Group Holdings Parent, Inc.CONthis companyP/E ↓ discount$3.2B19.2x8.1x42.3%12.7x
Merit Medical Systems, Inc.MMSI$3.8B29.3x2.4x8.1%12.5x
ACADIA Pharmaceuticals Inc.ACAD$3.7B9.5x3.0x31.9%30.8x
Organon & Co.OGN$3.5B18.8x4.7x24.9%9.0x
ICU Medical, Inc.ICUI$3.4B4607.1x1.6x0.0%14.7x
Integer Holdings CorporationITGR$3.1B30.6x1.8x5.9%15.2x
Arcus Biosciences, Inc.RCUS$3.1B-8.8x4.9x-55.9%-8.9x
National HealthCare CorporationNHC$2.9B24.5x2.7x11.2%13.7x
Privia Health Group, Inc.PRVA$2.7B117.5x3.7x3.1%50.4x
Peer median—26.9x2.9x7.0%14.2x

Year-to-date ROI

CON since 1 January, against earlier years.

Historical volatility

CON's day-to-day swings over 30, 60 and 180 days.

Financial statements

Income statement, balance sheet and cash flow as reported, grouped into plain-language lines.

Consolidated figures in USD, fiscal years, newest first.

Operating margin by fiscal year

Concentra Group Holdings Parent, Inc. operating margin by fiscal year
Concentra Group Holdings Parent, Inc. operating margin by fiscal year
DateOperating margin
FY202215.0%
FY202315.6%
FY202416.0%
FY202515.4%
LineFY2025
Cost of revenueCost Of Revenue$1.6B
Gross profitGross Profit$613.1M
Operating expensesOperating Expense$279.1M
Other operating expensesOther Operating Expenses-$20.0k
Depreciation and amortisationDepreciation And Amortization In Income Statement$75.8M
Depreciation, amortisation and depletionDepreciation Amortization Depletion Income Statement$75.8M
Total expensesTotal Expenses$1.8B
Pretax incomePretax Income$223.8M

Learn while you research

Academy chapters picked for Concentra Group Holdings Parent, Inc. and the metrics on this page.

  1. 01 Stock Valuation BasicsHow to think about what a fair price for a stock looks like.7 min read
  2. 02 Leverage RatiosDebt/Equity of 5.35 is elevated, understand what that means for solvency.6 min read
  3. 03 Sector Analysis MattersHealthcare valuation is driven by pipelines and regulation, not just numbers.6 min read
  4. 04 Essential Stock RatiosP/E, P/B, EV/EBITDA, what they mean and when to use each.7 min read
  5. 05 How to Read a Cash-Flow StatementProfit can be manipulated; cash flow rarely lies.7 min read
Browse the full Equiscale Academy →